SCHEMBL1633573

SCHEMBL1633573

NS(=O)(=O)c1ccc(Nc2ncc3cc(F)cc(-c4ccc(NCCN5CCCC5)nc4)c3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
CCNT1 O60563 5/20 0.43
CDK1 P06493 5/20 0.43
CCNE1 P24864 5/20 0.43
CDK2 P24941 5/20 0.43
CDK9 P50750 5/20 0.43
CDK5R1 Q15078 5/20 0.43
CDK5 Q00535 3/20 0.43
CCNB2 O95067 2/20 0.43
CCNE2 O96020 2/20 0.43
CCNB1 P14635 2/20 0.43
CCNB3 Q8WWL7 2/20 0.43
NTRK1 P04629 1/20 0.42
SRC P12931 5/20 0.42
CA4 P22748 2/20 0.42
BRAF P15056 1/20 0.41
PIK3CA P42336 1/20 0.41
PDGFRB P09619 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633540 0.92 CA1 (0.47) CA1CA2CA9CCNT1CDK1
SCHEMBL12764646 0.91 CA1 (0.46) CA1CA2CA9CCNT1CDK1
SCHEMBL1633268 0.91 CA1 (0.44) CA1CA2CA9CCNT1CDK1
SCHEMBL1634288 0.89 CA2 (0.44) CA1CA2CA9CCNT1CDK1
SCHEMBL1633149 0.88 CA1 (0.48) CA1CA2CA9CCNT1CDK1
SCHEMBL1633466 0.84 CA1 (0.48) CA1CA2CA9CCNT1CDK1
SCHEMBL1633507 0.84 NTRK1 (0.44) CA1CA2CA9CCNT1CDK1
SCHEMBL1634792 0.84 MAPK10 (0.43) CA1CA2CA9CCNT1CDK1
SCHEMBL13498265 0.83 NTRK1 (0.45) CA1CA2CA9CCNT1CDK1
SCHEMBL1633652 0.83 NTRK1 (0.43) CA1CA2CA9CCNT1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed